Related Experiment Video
Updated: Feb 12, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis
Julie Jézéquel1, Marilyn Lepleux1, Rene S Kahn1
1From the Interdisciplinary Institute for Neuroscience, Université de Bordeaux, UMR 5297, Bordeaux, France; CNRS, IINS UMR 5297, Bordeaux, France; the Icahn School of Medicine at Mount Sinai, New York; Institut NeuroMyoGène INSERM U1217/CNRS UMR 5310, Université Claude Bernard Lyon 1, Lyon, France; the Department of Psychiatry, Université Paris Est Créteil, Hôpitaux Universitaires Henri Mondor, AP-HP, DHU PePSY, France; the Translational Psychiatry Laboratory, INSERM U955, France; and FondaMental Foundation, France.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Internal Receptors
Molecular Models

